Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) → 4-chloro-2-fluoro-5-[4-(3-fluorophenyl)-4-[2-[(1R,5S)-3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]ethyl]piperidine-1-carbonyl]-N-propyl-benzenesulfonamide

Beteiligte Stoffe

Reaktionsschritte

0.366 g (0.82 mmol) 1-((1R,5S)-8-{2-[4-(3-fluorophenyl)piperidinyl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1H-benzimidazole and 0.363 g (1.23 mmol) 2-chloro-4-fluoro-5-[(propylamino)sulfonyl]benzoic acid were combined following the HATU general procedure in Example 5. This compound was purified by flash chromatography on a 0-100% gradient of 90:5:5 acetonitrile: ammonium hydroxide: water in acetonitrile. 0.24 g obtained (40% yield). 1H NMR (300 MHz, DMSO-d6) δ 8.04-8.15 (br, 1H), 7.69-7.90 (m, 2H), 7.32-7.52 (m, 3H), 7.19-7.26 (m, 2H), 7.01-7.15 (m, 3H), 4.41-4.56 (m, 1H), 3.86-3.98 (m, 1H), 3.19-3.43 (m, 6H), 2.97-3.08 (m, 1H), 2.77-2.88 (m, 2H), 2.44 (s, 3H), 2.28-2.41 (m, 2H), 1.96-2.17 (m, 2H), 1.71-1.92 (m, 9H), 1.56-1.64 (m, 2H), 1.31-1.42 (m, 2H), 0.73-0.81 (m, 3H).

Herkunft & Nachweise